Ranitidine (Zantac®) Syrup versus Ranitidine Effervescent Tablets (Zantac® EFFERdose®) in Children

[1]  David Toll,et al.  How Do You Improve Compliance? , 2005, Pediatrics.

[2]  D. Keininger,et al.  Simultaneous development of the Pediatric GERD Caregiver Impact Questionnaire (PGCIQ) in American English and American Spanish , 2005, Health and quality of life outcomes.

[3]  H. El‐Serag,et al.  Childhood GERD is a Risk Factor for GERD in Adolescents and Young Adults , 2004, American Journal of Gastroenterology.

[4]  P. Dobkin,et al.  Pediatric adherence as a multidimensional and dynamic construct, involving a triadic partnership. , 2004, Journal of pediatric psychology.

[5]  B. Gold.  Epidemiology and management of gastro‐oesophageal reflux in children , 2004, Alimentary pharmacology & therapeutics.

[6]  C. Rudolph.  Supraesophageal complications of gastroesophageal reflux in children: challenges in diagnosis and treatment. , 2003, The American journal of medicine.

[7]  D. Gibb,et al.  Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial , 2003, The Pediatric infectious disease journal.

[8]  G. Barnes,et al.  Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. , 2002, Journal of pediatric gastroenterology and nutrition.

[9]  A. Ciociola,et al.  Ranitidine, 75 mg, over‐the‐counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro‐oesophageal reflux , 2002, Alimentary pharmacology & therapeutics.

[10]  R. Baker,et al.  Guidelines for Evaluation and Treatment of Gastroesophageal Reflux in Infants and Children: Recommendations of the North American Society for Pediatric Gastroenterology and Nutrition , 2001, Journal of pediatric gastroenterology and nutrition.

[11]  K. Christoffel,et al.  Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Pediatric Practice Research Group. , 1997, Archives of pediatrics & adolescent medicine.

[12]  K. Christoffel,et al.  Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Pediatric Practice Research Group. , 1997, Archives of pediatrics & adolescent medicine.

[13]  G. Finley,et al.  Efficacy, duration, and absorption of a paediatric oral liquid preparation of ranitidine hydrochloride , 1992, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[14]  N. Goudsouzian,et al.  The efficacy of ranitidine in children , 1987, Acta anaesthesiologica Scandinavica.

[15]  J. Wren,et al.  Gastroesophageal Reflux in Children , 1987, Clinical pediatrics.

[16]  D. Jack,et al.  RANITIDINE AND PARACETAMOL METABOLISM , 1985, The Lancet.

[17]  J. Blumer,et al.  Pharmacokinetic determination of ranitidine pharmacodynamics in pediatric ulcer disease. , 1985, The Journal of pediatrics.

[18]  E. Mallet,et al.  Use of ranitidine in young infants with gastro-oesophageal reflux , 2004, European Journal of Clinical Pharmacology.

[19]  V. Tolia,et al.  Flavor and Taste of Lansoprazole Strawberry-Flavored Delayed-Release Oral Suspension Preferred over Ranitidine Peppermint-Flavored Oral Syrup , 2004, Paediatric drugs.

[20]  Wilson Ka.  Concordance and children's use of medicines , 2003 .